Peptide therapies
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
384
NCT05965414
Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers
Phase: Early Phase 1
Role: Lead Sponsor
Start: Oct 23, 2023
Completion: Jul 31, 2024
NCT06495528
Bliss DTx Assessment During Course Care Including Port-A-Catheter Setting
Phase: N/A
Start: Jun 12, 2024
Completion: May 12, 2025
Loading map...